amobarbital has been researched along with Atrophy in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "MRI-HS correlated with a history of febrile seizures and pathologically demonstrated hippocampal sclerosis." | 1.30 | FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome. ( Azzarelli, B; Ghetti, B; Hutchins, G; Markand, O; Park, H; Salanova, V; Smith, R; Wellman, H; Worth, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salanova, V | 1 |
| Markand, O | 1 |
| Worth, R | 1 |
| Smith, R | 1 |
| Wellman, H | 1 |
| Hutchins, G | 1 |
| Park, H | 1 |
| Ghetti, B | 1 |
| Azzarelli, B | 1 |
1 other study available for amobarbital and Atrophy
| Article | Year |
|---|---|
FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome.
Topics: Adolescent; Adult; Amobarbital; Atrophy; Carotid Artery, Internal; Child; Electroencephalography; Ep | 1998 |